Arthritis Pain: A Clue to Bone Disease

Minkin, Mary Jane; Hanlon, Toby
October 2001
Prevention;Oct2001, Vol. 53 Issue 10, p160
Discusses Paget's disease, the second most common bone disease in the United States after osteoporosis.


Related Articles

  • Paget's disease of bone: A review. Schwartz, Ernest // Cortlandt Forum;12/21/98, Vol. 11 Issue 12, p258 

    Provides information on Paget's disease. Manifestations of the disease; Changes in the diagnostic process; Symptoms; Differences between a pagetic bone and a normal bone; Treatment approaches.

  • Paget's Disease of Bone (Osteitis Deformans): Symptomatic Lesions and Bone Scan. Khairi, M. R. A.; Wellman, H. N.; Robb, J. A.; Johnston, C. C. // Annals of Internal Medicine;Sep73, Vol. 79 Issue 3, p348 

    Focuses on a study that analyzed the symptomatic and asymptomatic bony lesions in a group of several patients with Paget's disease. Patients and methods; Results; Discussion.

  • Treatment of Patients with Paget's Disease of Bone. Roux, C.; Dougados, M. // Drugs;Nov1999, Vol. 58 Issue 5, p823 

    Paget's disease is a progressive bone disease, monostotic or polyostotic, characterised by hypertrophy of affected bones and accelerated disorganised bone remodelling. It results in bone deformities and pain, with a risk for articular and neurological complications, and fractures. The risk of...

  • Paget's disease of bone: A new philosophy of treatment. Hines, Silvia E.; Ankrom, Michael A. // Patient Care;12/15/1999, Vol. 33 Issue 20, p40 

    Discusses the diagnosis, treatment and prevention of Paget's disease of bone. Signs and symptoms manifested by asymptomatic and symptomatic patients; List of drugs for treating Paget's disease of bone; Side-effects of these drugs. INSETS: Living with Paget's disease of bone.;Current concepts...

  • Paget's osteosarcoma - no cure in sight. Shaylor, Phillip J.; Peake, David; Grimer, Robert J.; Carter, Simon R.; Tillman, Roger M.; Spooner, David // Sarcoma;Dec1999, Vol. 3 Issue 3/4, p191 

    Purpose Paget's osteosarcoma has a fearful reputation with a quoted survival of at best 5% at 5 years. We therefore reviewed our experience of 26 patients treated over the last 25 years using modern staging and limb salvage techniques to see if there had been any improvement in survival....

  • Calcium gluconate/denosumab.  // Reactions Weekly;9/28/2013, Issue 1471, p14 

    The article presents a case study of an 8-year-old girl, who developed severe hypocalcaemia during the treatment of juvenile Paget's disease with denosumab, calcium supplementation with calcium gluconate.

  • Osteoprotegerin Deficiency and Juvenile Paget's Disease. Whyte, Michael P.; Obrecht, Sara E.; Finnegan, Patrick M.; Jones, Jonathan L.; Podgornik, Michelle N.; McAlister, William H.; Mumm, Steven // New England Journal of Medicine;7/18/2002, Vol. 347 Issue 3, p175 

    Background: Juvenile Paget's disease, an autosomal recessive osteopathy, is characterized by rapidly remodeling woven bone, osteopenia, fractures, and progressive skeletal deformity. The molecular basis is not known. Osteoprotegerin deficiency could explain juvenile Paget's disease because...

  • radiologic case study. Hassell, Douglass; Schils, Jean; Joyce, Michael; Bauer, Thomas; Sundaram, Murali // Orthopedics;Jul2005, Vol. 28 Issue 7, p620 

    Presents a case study of a patient with lytic phase of Paget disease. Manifestations of the condition; Etiology and diagnosis of the disease; Treatment for the condition.

  • Average Hat Size Falls in New Zealand. Sorbie, Charles // Orthopedics;Mar2003, Vol. 26 Issue 3, p271 

    The article reports on the decline of the prevalence of Paget's disease in New Zealand. The cause of the disease remains elusive although the bone changes have been well researched with the use of histology and blood chemistry. The prevalence of the disease declined by 50 percent over the past...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics